HIV and AIDS Immunity Drug Makes Medical Advancement
Wednesday, December 26th, 2007
The Food and Drug Administration approved the use of a drug called Maraviroc for treating the HIV virus this year. The drug, also known by the brand name Selzentry, blocks the CCR5 cell receptor the HIV virus uses to invade and infect white blood cells, invariably slowing down a patient’s immunity breakdown. This is the first HIV or AIDS drug to work in this way in early stages of HIV. Because the drug is new, side-effects are still be studied but early usage of Selzentry has been positive.

Every year, almost 25,000 American women are diagnosed with ovarian cancer. Of those women, 4 in 5 find that the cancer has spread beyond their ovaries, making surviving the disease nearly impossible. It is no wonder that women fear this disease so much in our society. There is some hope though. If ovarian cancer is caught before it is spread, 90% of women will live longer than 5 years. Unfortunately right now good testing is hard to come by. Research is being done but at a rate too slow to save many women. So how can you, your sister, or your mother help detect this cancer? Follow these detection tips from key researchers and doctors from the country’s leading cancer institutes collected by